Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017175854) 1,5-BENZODIAZEPINE COMPOUND CRYSTAL
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/175854 International Application No.: PCT/JP2017/014486
Publication Date: 12.10.2017 International Filing Date: 07.04.2017
IPC:
C07D 243/12 (2006.01) ,A61K 31/551 (2006.01) ,A61P 1/04 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
D
HETEROCYCLIC COMPOUNDS
243
Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
06
having the nitrogen atoms in positions 1 and 4
10
condensed with carbocyclic rings or ring systems
12
1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
55
having seven-membered rings, e.g. azelastine, pentylenetetrazole
551
having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1
Drugs for disorders of the alimentary tract or the digestive system
04
for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applicants:
ゼリア新薬工業株式会社 ZERIA PHARMACEUTICAL CO., LTD. [JP/JP]; 東京都中央区日本橋小舟町10番11号 10-11, Nihonbashi Kobuna-cho, Chuo-ku, Tokyo 1038351, JP
Inventors:
中尾 竜 NAKAO, Ryu; JP
Agent:
特許業務法人アルガ特許事務所 THE PATENT CORPORATE BODY ARUGA PATENT OFFICE; 東京都中央区日本橋人形町1丁目3番8号 沢の鶴人形町ビル Sawanotsuru Ningyocho Bldg., 1-3-8, Nihonbashi Ningyocho, Chuo-ku, Tokyo 1030013, JP
Priority Data:
2016-07825408.04.2016JP
Title (EN) 1,5-BENZODIAZEPINE COMPOUND CRYSTAL
(FR) CRISTAL DE COMPOSÉ 1,5-BENZODIAZÉPINE
(JA) 1,5-ベンゾジアゼピン化合物の結晶
Abstract:
(EN) The present invention provides a novel crystal of a compound A, the novel crystal being usable as a pharmaceutical product. Provided is a IV-type crystal of calcium (R)-(-)-3-[3-(1-tert-butylcarbonylmethyl-2-oxo-5-cyclohexyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-3-yl)ureido]benzoate characterized by having characteristic peaks at diffraction angles (2θ±0.2°) of 7.94°, 8.50°, 10.27°, 12.30°, 12.83°, 13.93°, 17.19°, 19.04°, 20.57°, and 23.94° in a powder X-ray diffraction spectrum.
(FR) L’invention fournit un nouveau cristal d’un composant A permettant une mise en œuvre en tant que médicament. Plus précisément, l’invention concerne un cristal de type IV de (R)-(-)-3-〔3-(1-tert-butylcarbonylméthyl-2-oxo-5-cyclohexyl-1,3,4,5-tétrahydro-2H-1,5-benzodiazépine-3-yl)uréide〕benzoate de calcium qui est caractéristique en ce que, dans un spectre de diffraction de rayons X sur poudres, il présente des pics caractéristiques aux angles de diffraction (2θ±0.2°) 7,94°, 8,50°, 10,27°, 12,30°, 12,83°, 13,93°, 17,19°, 19,04°, 20,57° et 23,94°.
(JA) 医薬品として使用可能な化合物Aの新規結晶の提供。 粉末X線回折スペクトルにおいて、回折角(2θ±0.2°)が7.94°、8.50°、10.27°、12.30°、12.83°、13.93°、17.19°、19.04°、20.57°及び23.94°の特徴的なピークを有することを特徴とする、(R)-(-)-3-〔3-(1-tert-ブチルカルボニルメチル-2-オキソ-5-シクロヘキシル-1,3,4,5-テトラヒドロ-2H-1,5-ベンゾジアゼピン-3-イル)ウレイド〕安息香酸 カルシウムのIV型結晶。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)